Literature DB >> 10959690

Plasma concentration of von Willebrand factor in acute myocardial infarction.

H Sakai1, S Goto, J Y Kim, N Aoki, S Abe, N Ichikawa, M Yoshida, Y Nagaoka, S Handa.   

Abstract

Recent investigations have revealed the crucial role of von Willebrand factor (vWF) in platelet thrombus formation under flow conditions. The plasma concentrations of vWF were measured together with various hemodynamic and hemostatic parameters in 51 cases of acute myocardial infarction. In 10 randomly selected cases, the plasma concentrations and distribution of multimers vWF were serially determined after reperfusion therapy by percutaneous transluminal coronary angioplasty (PTCA). The vWF concentration at the onset of the acute myocardial infarction was significantly higher than in an age-matched control group (vWF AG: 18.7 +/- 1.2 microg/ml vs. 10.3 +/- 0.5 microg/ml, p = 8.43 x 10-(12), mean +/- SE). Simultaneous determination of hemodynamic and hemostatic parameters revealed that the only two parameters that were significantly correlated with the patients' plasma vWF concentrations were their pulmonary capillary wedge pressure (PCWP) and heart rate, suggesting a relationship between hemodynamic changes induced by the onset of myocardial infarction and the vWF plasma concentrations. Serial determinations revealed that the vWF concentrations had not changed 1 h after reperfusion therapy, but that they significantly increased by 24 to 72 h. The distribution of the larger multimers of vWF also increased in the acute and subacute phase. The vWF concentration and multimer distribution normalized 14 days after the onset of the myocardial infarction. Our findings suggest that the vWF concentration increased in acute myocardial infarction patients, possibly in association with the hemodynamic deterioration that occurs in acute myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10959690

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  13 in total

1.  Recognition of PF4-VWF complexes by heparin-induced thrombocytopenia antibodies contributes to thrombus propagation.

Authors:  Ian Johnston; Amrita Sarkar; Vincent Hayes; Gavin T Koma; Gowthami M Arepally; Junmei Chen; Dominic W Chung; José A López; Douglas B Cines; Lubica Rauova; Mortimer Poncz
Journal:  Blood       Date:  2020-04-09       Impact factor: 25.476

2.  Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.

Authors:  Manabu Horii; Shiro Uemura; Masahito Uemura; Masanori Matsumoto; Hiromichi Ishizashi; Keiichi Imagawa; Hajime Iwama; Yukiji Takeda; Hiroyuki Kawata; Tamio Nakajima; Yoshihiro Fujimura; Yoshihiko Saito
Journal:  Heart Vessels       Date:  2008-09-20       Impact factor: 2.037

3.  Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice.

Authors:  Simon F De Meyer; Alexander S Savchenko; Michael S Haas; Daphne Schatzberg; Michael C Carroll; Alexandra Schiviz; Barbara Dietrich; Hanspeter Rottensteiner; Friedrich Scheiflinger; Denisa D Wagner
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

4.  Von Willebrand factor and oxidative stress parameters in acute coronary syndromes.

Authors:  Zoran Koprivica; Dusica Djordjevic; Milena Vuletic; Vladimir Zivkovic; Nevena Barudzic; Nebojsa Andjelkovic; Dragan Djuric; Violeta Iric-Cupic; Jelena Krkeljic; Vladimir Jakovljevic
Journal:  Oxid Med Cell Longev       Date:  2011-08-08       Impact factor: 6.543

Review 5.  Update on von Willebrand factor multimers: focus on high-molecular-weight multimers and their role in hemostasis.

Authors:  Marcus Stockschlaeder; Reinhard Schneppenheim; Ulrich Budde
Journal:  Blood Coagul Fibrinolysis       Date:  2014-04       Impact factor: 1.276

6.  Kinetics of plasma von Willebrand factor in acute myocardial infarction patients: a meta-analysis.

Authors:  Xia Wang; Junyu Zhao; Yong Zhang; Xiujuan Xue; Jie Yin; Lin Liao; Cuiping Xu; Yinglong Hou; Suhua Yan; Ju Liu
Journal:  Oncotarget       Date:  2017-08-09

7.  vWF correlates with visceral and pericardial adipose tissue in patients with a recent stroke of suspected cardiogenic etiology.

Authors:  Antti Tapani Muuronen; Mikko Taina; Juha Onatsu; Miika Korhonen; Kari Pulkki; Pekka Jäkälä; Ritva Vanninen; Pirjo Mustonen
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

8.  Circulating Proangiogenic Cells and Proteins in Patients with Glioma and Acute Myocardial Infarction: Differences in Neovascularization between Neoplasia and Tissue Regeneration.

Authors:  Karin Huizer; Andrea Sacchetti; Wim A Dik; Dana A Mustafa; Johan M Kros
Journal:  J Oncol       Date:  2019-07-21       Impact factor: 4.375

9.  Plasma von Willebrand factor level is transiently elevated in a rat model of acute myocardial infarction.

Authors:  Yan Li; Liqun Li; Fengyun Dong; Ling Guo; Yinglong Hou; Hesheng Hu; Suhua Yan; Xiaojun Zhou; Lin Liao; Thaddeus D Allen; J U Liu
Journal:  Exp Ther Med       Date:  2015-09-01       Impact factor: 2.447

10.  Effects of anti-β2GPI antibodies on VWF release from human umbilical vein endothelial cells and ADAMTS13 activity.

Authors:  Christopher J Ng; Keith R McCrae; Katrina Ashworth; Lucas J Sosa; Venkaiah Betapudi; Marilyn J Manco-Johnson; Alice Liu; Jing-Fei Dong; Dominic Chung; Tara C White-Adams; José A López; Jorge Di Paola
Journal:  Res Pract Thromb Haemost       Date:  2018-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.